Immune recovery after low-dose Campath therapy in a group of pretreated patients affected by B-cell chronic lymphocytic leukemia
Open Access
- 21 October 2004
- journal article
- other
- Published by Springer Nature in Leukemia
- Vol. 19 (1) , 153-154
- https://doi.org/10.1038/sj.leu.2403561
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Immune Recovery of Lymphocyte Subsets 6 Years after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) for Lymphoproliferative Diseases. A Comparison between NHL, HD and MM in Group of 149 PatientsLeukemia & Lymphoma, 2004
- Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemiaLeukemia, 2004
- Immune reconstitution after autologous selectedperipheral blood progenitor cell transplantation:comparison of two CD34+ cell‐selection systemsTransfusion, 2001
- Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplantsBritish Journal of Haematology, 2000
- Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell TransplantationBlood, 1998